150 related articles for article (PubMed ID: 28062627)
1. Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study.
Hughes MF; Ojeda F; Saarela O; Jørgensen T; Zeller T; Palosaari T; O'Doherty MG; Borglykke A; Kuulasmaa K; Blankenberg S; Kee F
Clin Chem; 2017 Jan; 63(1):334-342. PubMed ID: 28062627
[TBL] [Abstract][Full Text] [Related]
2. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
[TBL] [Abstract][Full Text] [Related]
4. High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals.
Thorsteinsdottir I; Aspelund T; Gudmundsson E; Eiriksdottir G; Harris TB; Launer LJ; Gudnason V; Venge P
Clin Chem; 2016 Apr; 62(4):623-30. PubMed ID: 26936931
[TBL] [Abstract][Full Text] [Related]
5. Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study).
Lyngbakken MN; Skranes JB; de Lemos JA; Nygård S; Dalen H; Hveem K; Røsjø H; Omland T
Circulation; 2016 Dec; 134(24):1962-1972. PubMed ID: 27815376
[TBL] [Abstract][Full Text] [Related]
6. Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study.
Lyngbakken MN; Røsjø H; Holmen OL; Dalen H; Hveem K; Omland T
Clin Chem; 2019 Jul; 65(7):871-881. PubMed ID: 30996050
[TBL] [Abstract][Full Text] [Related]
7. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study.
Omland T; de Lemos JA; Holmen OL; Dalen H; Benth JŠ; Nygård S; Hveem K; Røsjø H
Clin Chem; 2015 Apr; 61(4):646-56. PubMed ID: 25695851
[TBL] [Abstract][Full Text] [Related]
8. High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium.
Yan I; Börschel CS; Neumann JT; Sprünker NA; Makarova N; Kontto J; Kuulasmaa K; Salomaa V; Magnussen C; Iacoviello L; Di Castelnuovo A; Costanzo S; Linneberg A; Söderberg S; Zeller T; Ojeda-Echevarria FM; Blankenberg S; Westermann D
JACC Heart Fail; 2020 May; 8(5):401-411. PubMed ID: 32171759
[TBL] [Abstract][Full Text] [Related]
9. Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.
Jansen H; Jaensch A; Schöttker B; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
J Am Heart Assoc; 2019 Jun; 8(12):e011882. PubMed ID: 31189389
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
Bargnoux AS; Kuster N; Patrier L; Dupuy AM; Tachon G; Maurice F; Badaoui B; Chalabi L; Badiou S; Deleuze S; Leray-Moragues H; Morena M; Canaud B; Cristol JP
Clin Chem Lab Med; 2016 Apr; 54(4):673-82. PubMed ID: 26457775
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity cardiac troponin I and risk of incident atrial fibrillation hospitalisation in an Australian community-based cohort: The Busselton health study.
Zhu K; Hung J; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Knuiman M
Clin Biochem; 2018 Aug; 58():20-25. PubMed ID: 29746826
[TBL] [Abstract][Full Text] [Related]
12. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
Jarolim P; Claggett BL; Conrad MJ; Carpenter MA; Ivanova A; Bostom AG; Kusek JW; Hunsicker LG; Jacques PF; Gravens-Mueller L; Finn P; Solomon SD; Weiner DE; Levey AS; Pfeffer MA
Transplantation; 2017 Jan; 101(1):182-190. PubMed ID: 26910333
[TBL] [Abstract][Full Text] [Related]
13. High-Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study).
Lan NSR; Bell DA; McCaul KA; Vasikaran SD; Yeap BB; Norman PE; Almeida OP; Golledge J; Hankey GJ; Flicker L
J Am Heart Assoc; 2019 Mar; 8(5):e011818. PubMed ID: 30819029
[TBL] [Abstract][Full Text] [Related]
14. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
[No Abstract] [Full Text] [Related]
15. Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
Lima BB; Hammadah M; Kim JH; Uphoff I; Shah A; Levantsevych O; Almuwaqqat Z; Moazzami K; Sullivan S; Ward L; Sun Y; Kutner M; Ko YA; Sheps DS; Beshiri A; Murtagh G; Bremner JD; Vaccarino V; Quyyumi AA
Am J Cardiol; 2020 Dec; 136():1-8. PubMed ID: 32941818
[TBL] [Abstract][Full Text] [Related]
16. Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.
Jansen H; Jänsch A; Breitling LP; Hoppe L; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
Int J Cardiol; 2018 Jan; 250():247-252. PubMed ID: 29169757
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome.
Árnadóttir Á; Vestergaard KR; Pallisgaard J; Sölétormos G; Steffensen R; Goetze JP; Iversen K
Int J Cardiol; 2018 May; 259():186-191. PubMed ID: 29477263
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive Troponin I and Incident Cardiovascular Disease.
Empana JP; Lerner I; Perier MC; Guibout C; Jabre P; Bailly K; Andrieu M; Climie R; van Sloten T; Vedie B; Geromin D; Marijon E; Thomas F; Danchin N; Boutouyrie P; Jouven X
Arterioscler Thromb Vasc Biol; 2022 Dec; 42(12):1471-1481. PubMed ID: 36325900
[TBL] [Abstract][Full Text] [Related]
19. Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study.
Kimenai DM; Martens RJH; Kooman JP; Stehouwer CDA; Tan FES; Schaper NC; Dagnelie PC; Schram MT; van der Kallen CJH; Sep SJS; van Suijlen JDE; Kroon AA; Bekers O; van Dieijen-Visser MP; Henry RMA; Meex SJR
Sci Rep; 2017 Jul; 7(1):6610. PubMed ID: 28747765
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.
Kavsak PA; Xu L; Yusuf S; McQueen MJ
Clin Chem; 2011 Aug; 57(8):1146-53. PubMed ID: 21700956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
